Antitumor activity of imidazolium-bisimidazole-tetrachlororuthenate (III) - A representative of a new class of inorganic antitumor agents

Journal of Cancer Research and Clinical Oncology

Volumn 111, Issue 2, 1986, Pages 166-168

  Keppler, B K ^a   Rupp, W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Antitumor activity ity; Imidazolium bisimidazoletetrachlororuthenate (III); Ruthenium complex

Indexed keywords

ANTINEOPLASTIC AGENT;

ANIMAL MODEL; BLOOD AND HEMOPOIETIC SYSTEM; CANCER CHEMOTHERAPY; IMIDAZOLIUM TETRACHLOROBIS(IMIDAZOLE)RUTHENATE; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA; LEUKEMIA P 388; MELANOMA; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERAPY;

ANIMAL; ANTINEOPLASTIC AGENTS; CISPLATIN; COMPARATIVE STUDY; CYCLOPHOSPHAMIDE; DRUG EVALUATION, PRECLINICAL; FEMALE; FLUOROURACIL; IMIDAZOLES; LEUKEMIA P388; MELANOMA; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; RUTHENIUM;

EID: 0022649260     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/BF00400758     Document Type: Article

References (9)

1. Biological characterization and chemotherapy of autochthonous colorectal tumors in rats
2. Oncological implications of the chemistry of ruthnium
3. Antitumor properties of metal complexes
4. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato)-titanium(IV) compounds against Walker 256 carcinosarcoma
5. Antitumor activity of phenyl substituted dihalogenobis(1-phenyl-1,3-butanedionato)titanium-(IV) compounds
6. Komplexverbindungen des Rutheniums mit fünfzähligen heterocyclischen Basen II. Reaktionen des Ruthenium(III)-Chlorids mit Pyrazol und Imidazol
7. Cis-diamminedichloroplatin(II)
8. Platinum compounds: a new class of potent antitumor agents